Clinical trial
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 13, 2014
- Completion date
- March 16, 2015
- Enrollment
- 188 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.